跳至主要内容
临床试验/JPRN-UMIN000031541
JPRN-UMIN000031541招募中未知

Multi-disciplinary research for predictive factors of nivolumab effect on unresectable or metastatic renal cell carcinoma - Biomarker exploratory research for nivolumab in renal cell carcinoma

Graduate School of Pharmaceutical Sciences Department of Urology, Graduate School of Medicine Osaka University0 个研究点目标入组 30 人开始时间: 2018年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Patients with known or previous antoimmune disease 2)Patients who are currently administered corticosteroids 3)Patients with prior therapy by antibody or drug, specifically aiming at regulation of T-cell functions 4)Patients with history of serious anaphylaxis induced by the component of this agent 5)Dementia or psychological disorder difficult to participate in this clinical study 6)Patients with severe complications (active gastrointestinal ulceration, ileus, bowel obstruction, and uncontrolled diabetes mellitus, etc.) 7)Patients with HIV antibody-positive, HBs antibody-positive, or HCV antibody-positive 8)Patients with HBs antigen-negative, HBs antibody- or HBc antibody-positive, and HBV-DNA quantitative test-positive 9)Pregnant or breast-feeding women or women suspected of being pregnant 10)Other cases judged inappropriate by the attending

研究者

发起方
Graduate School of Pharmaceutical Sciences Department of Urology, Graduate School of Medicine Osaka University

相似试验